Kenji Ihara

Prof. Kenji Ihara

Oita University, Ōita, Japan
orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2016 in Nature Genetics
Verified
Journal Article
Closed access
SNSatoshi Narumi
Satoshi Narumi
NANaoko Amano
Naoko Amano
Tomohiro IshiiTomohiro Ishii
Tomohiro Ishii
NKNoriyuki Katsumata
Noriyuki Katsumata
KMKoji Muroya
Koji Muroya
THTomonobu Hasegawa
Tomonobu Hasegawa

16 March 1999 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
KIKenji Ihara
Kenji Ihara
EIEiichi Ishii
Eiichi Ishii
MEMariko Eguchi
Mariko Eguchi
HTHidetoshi Takada
Hidetoshi Takada
ASAiko Suminoe
Aiko Suminoe
THToshiro Hara
Toshiro Hara
Congenital amegakaryocytic thrombocytopenia (CAMT) is a rare disorder expressed in infancy and characterized by isolated thrombocytopenia and megakaryocytopenia with no physical anomalies. Our previous hematological analysis indicated similarities between human CAMT and murine c-mpl (thrombopoietin receptor) deficiency. Because the c-mpl gene was considered as one of the candidate genes for this disorder, we analyzed the genomic sequence of the c-mpl gene of a 10-year-old Japanese girl with CAMT. We detected two heterozygous point mutations: a C-to-T transition at the cDNA nucleotide position 556 (Q186X) in exon 4 and a single nucleotide deletion of thymine at position 1,499 (1,499 delT) in exon 10. Both mutations were predicted to result in a prematurely terminated c-Mpl protein, which, if translated, lacks all intracellular domains essential for signal transduction. Each of the mutations was segregated from the patient’s parents. Accordingly, the patient was a compound heterozygote for two mutations of the c-mpl gene, each derived from one of the parents. The present study suggests that at least a certain type of CAMT is caused by the c-mpl mutation, which disrupts the function of thrombopoietin receptor.

2 August 2013 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
NMNoriko Miyake
Noriko Miyake
EKEriko Koshimizu
Eriko Koshimizu
NONobuhiko Okamoto
Nobuhiko Okamoto
SMSeiji Mizuno
Seiji Mizuno
TOTsutomu Ogata
Tsutomu Ogata
NNNorio Niikawa
Norio Niikawa

17 August 2015 in Scientific Reports
Verified
Journal Article
Open access
PDF file
KOKazuhiro Ohkubo
Kazuhiro Ohkubo
YSYasunari Sakai
Yasunari Sakai
HIHirosuke Inoue
Hirosuke Inoue
SASatoshi Akamine
Satoshi Akamine
YIYoshito Ishizaki
Yoshito Ishizaki
THToshiro Hara
Toshiro Hara
Moyamoya disease (MMD) is a cerebrovascular disorder characterized by occlusive lesions of the circle of Willis. To date, both environmental and genetic factors have been implicated for pathogenesis of MMD. Allelic variations in RNF213 are known to confer the risk of MMD; however, functional roles of RNF213 remain to be largely elusive. We herein report that pro-inflammatory cytokines, IFNG and TNFA, synergistically activated transcription of RNF213 both in vitro and in vivo. Using various chemical inhibitors, we found that AKT and PKR pathways contributed to the transcriptional activation of RNF213. Transcriptome-wide analysis and subsequent validation with quantitative PCR supported that endogenous expression of cell cycle-promoting genes were significantly decreased with knockdown of RNF213 in cultured endothelial cells. Consistently, these cells showed less proliferative and less angiogenic profiles. Chemical inhibitors for AKT (LY294002) and PKR (C16) disrupted their angiogenic potentials, suggesting that RNF213 and its upstream pathways cooperatively organize the process of angiogenesis. Furthermore, RNF213 down-regulated expressions of matrix metalloproteases in endothelial cells, but not in fibroblasts or other cell types. Altogether, our data illustrate that RNF213 plays unique roles in endothelial cells for proper gene expressions in response to inflammatory signals from environments.

28 June 2003 in Immunogenetics
Verified
Journal Article
Closed access
PDF file
WBWafaa M. Bassuny
Wafaa M. Bassuny
KIKenji Ihara
Kenji Ihara
YSYuka Sasaki
Yuka Sasaki
RKRyuichi Kuromaru
Ryuichi Kuromaru
HKHitoshi Kohno
Hitoshi Kohno
THToshiro Hara
Toshiro Hara

16 May 2013 in Journal of Human Genetics
Verified
Journal Article
Closed access
TITakahito Inoue
Takahito Inoue
KHKiyoko Hattori
Kiyoko Hattori
KIKenji Ihara
Kenji Ihara
AIAtsushi Ishii
Atsushi Ishii
KNKimitoshi Nakamura
Kimitoshi Nakamura
SHShinichi Hirose
Shinichi Hirose